352 related articles for article (PubMed ID: 15634780)
1. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease.
Andrews ZB; Horvath B; Barnstable CJ; Elsworth J; Yang L; Beal MF; Roth RH; Matthews RT; Horvath TL
J Neurosci; 2005 Jan; 25(1):184-91. PubMed ID: 15634780
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity.
Conti B; Sugama S; Lucero J; Winsky-Sommerer R; Wirz SA; Maher P; Andrews Z; Barr AM; Morale MC; Paneda C; Pemberton J; Gaidarova S; Behrens MM; Beal F; Sanna PP; Horvath T; Bartfai T
J Neurochem; 2005 Apr; 93(2):493-501. PubMed ID: 15816872
[TBL] [Abstract][Full Text] [Related]
3. Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease.
Horvath TL; Diano S; Leranth C; Garcia-Segura LM; Cowley MA; Shanabrough M; Elsworth JD; Sotonyi P; Roth RH; Dietrich EH; Matthews RT; Barnstable CJ; Redmond DE
Endocrinology; 2003 Jul; 144(7):2757-60. PubMed ID: 12810526
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism.
Andrews ZB; Erion D; Beiler R; Liu ZW; Abizaid A; Zigman J; Elsworth JD; Savitt JM; DiMarchi R; Tschoep M; Roth RH; Gao XB; Horvath TL
J Neurosci; 2009 Nov; 29(45):14057-65. PubMed ID: 19906954
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling protein-2 promotes nigrostriatal dopamine neuronal function.
Andrews ZB; Rivera A; Elsworth JD; Roth RH; Agnati L; Gago B; Abizaid A; Schwartz M; Fuxe K; Horvath TL
Eur J Neurosci; 2006 Jul; 24(1):32-6. PubMed ID: 16882005
[TBL] [Abstract][Full Text] [Related]
6. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
[TBL] [Abstract][Full Text] [Related]
7. The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels.
Lu M; Zhao FF; Tang JJ; Su CJ; Fan Y; Ding JH; Bian JS; Hu G
Antioxid Redox Signal; 2012 Sep; 17(6):849-59. PubMed ID: 22360462
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial uncoupling protein-2 (UCP2) mediates leptin protection against MPP+ toxicity in neuronal cells.
Ho PW; Liu HF; Ho JW; Zhang WY; Chu AC; Kwok KH; Ge X; Chan KH; Ramsden DB; Ho SL
Neurotox Res; 2010 May; 17(4):332-43. PubMed ID: 19763737
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial UCP4 attenuates MPP+ - and dopamine-induced oxidative stress, mitochondrial depolarization, and ATP deficiency in neurons and is interlinked with UCP2 expression.
Chu AC; Ho PW; Kwok KH; Ho JW; Chan KH; Liu HF; Kung MH; Ramsden DB; Ho SL
Free Radic Biol Med; 2009 Mar; 46(6):810-20. PubMed ID: 19150400
[TBL] [Abstract][Full Text] [Related]
10. Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation.
Lu M; Sun XL; Qiao C; Liu Y; Ding JH; Hu G
Neurobiol Aging; 2014 Feb; 35(2):421-30. PubMed ID: 24041971
[TBL] [Abstract][Full Text] [Related]
11. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
12. UCP2 knockout suppresses mouse skin carcinogenesis.
Li W; Zhang C; Jackson K; Shen X; Jin R; Li G; Kevil CG; Gu X; Shi R; Zhao Y
Cancer Prev Res (Phila); 2015 Jun; 8(6):487-91. PubMed ID: 25784177
[TBL] [Abstract][Full Text] [Related]
13. MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT.
Bentea E; Sconce MD; Churchill MJ; Van Liefferinge J; Sato H; Meshul CK; Massie A
Neurosci Lett; 2015 Apr; 593():1-6. PubMed ID: 25766755
[TBL] [Abstract][Full Text] [Related]
14. UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis.
Peixoto PM; Kim HJ; Sider B; Starkov A; Horvath TL; Manfredi G
Mol Cell Neurosci; 2013 Nov; 57():104-10. PubMed ID: 24141050
[TBL] [Abstract][Full Text] [Related]
15. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.
Breidert T; Callebert J; Heneka MT; Landreth G; Launay JM; Hirsch EC
J Neurochem; 2002 Aug; 82(3):615-24. PubMed ID: 12153485
[TBL] [Abstract][Full Text] [Related]
16. Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion.
Oeckl P; Scheffold A; Lechel A; Rudolph KL; Ferger B
Neuroreport; 2014 Mar; 25(5):335-9. PubMed ID: 24525820
[TBL] [Abstract][Full Text] [Related]
17. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress.
You LH; Li Z; Duan XL; Zhao BL; Chang YZ; Shi ZH
Brain Res; 2016 Jul; 1642():33-42. PubMed ID: 27017962
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
[TBL] [Abstract][Full Text] [Related]
20. Increasing uncoupling protein-2 in pancreatic beta cells does not alter glucose-induced insulin secretion but decreases production of reactive oxygen species.
Produit-Zengaffinen N; Davis-Lameloise N; Perreten H; Bécard D; Gjinovci A; Keller PA; Wollheim CB; Herrera P; Muzzin P; Assimacopoulos-Jeannet F
Diabetologia; 2007 Jan; 50(1):84-93. PubMed ID: 17131143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
